Pharma Equity Group A/S (CPH: PEG)

Pharma Equity Group Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	0.86	4.23	2.83
Cash & Short-Term Investments	0.86	4.23	2.83
Cash Growth	-75.43%	49.51%	-
Other Receivables	2.37	4.58	2.66
Receivables	60.37	62.58	2.66
Inventory	-	0.41	1.59
Prepaid Expenses	0.53	0.01	-
Total Current Assets	61.76	67.23	7.07
Property, Plant & Equipment	0.39	0.51	0.58
Other Intangible Assets	13.47	13.6	13.86
Other Long-Term Assets	1.02	-0	-
Total Assets	76.64	81.34	21.52
Accounts Payable	4.6	10.2	1.61
Accrued Expenses	-	1.14	0.06
Short-Term Debt	25.03	21.93	-
Current Portion of Leases	0.23	0.22	0.29
Other Current Liabilities	2.26	0.85	0.36
Total Current Liabilities	32.11	34.33	2.31
Long-Term Debt	18.51	7.84	-
Long-Term Leases	0.12	0.23	0.3
Total Liabilities	50.74	42.4	2.61
Common Stock	1,023	1,023	0.83
Comprensive Income & Other	-997.06	-984.03	18.08
Shareholders' Equity	25.9	38.93	18.91
Total Liabilities & Equity	76.64	81.34	21.52
Total Debt	43.88	30.22	0.58
Net Cash (Debt)	-43.02	-25.99	2.25
Net Cash Per Share	-0.04	-0.02	0.00
Filing Date Shares Outstanding	1,023	1,023	953.97
Total Common Shares Outstanding	1,023	1,023	953.97
Working Capital	29.65	32.9	4.76
Book Value Per Share	0.03	0.04	0.02
Tangible Book Value	12.43	25.33	5.05
Tangible Book Value Per Share	0.01	0.02	0.01
Machinery	-	0.09	0.02

Source: S&P Capital IQ. Standard template. Financial Sources.